Image

Community Partnership for Telehealth Solutions to Counter Misinformation and Achieve Equity

Community Partnership for Telehealth Solutions to Counter Misinformation and Achieve Equity

Recruiting
45-64 years
All
Phase N/A

Powered by AI

Overview

Non-randomized, two-arm stepped-wedge trial of a multi-level colorectal cancer screening intervention.

Description

The PRIME study aims to improve colorectal cancer (CRC) screening and follow-up among predominantly Latinx populations by using video text messages, mailed FIT kits, and patient navigation. The study will address multi-level barriers to screening, including misinformation, lack of access, and social determinants of health. The hypothesis is that a multi-component intervention will increase CRC screening rates and follow-up care, reducing disparities in CRC outcomes.

Eligibility

Inclusion Criteria:

  • Ages 45-64
  • Eligible for colorectal cancer (CRC) screening
  • Current patients (seen in the clinic in the last 6 months)
  • Primary speaker of English or Spanish
  • Cell phone listed in Electronic Health Record (EHR)
  • No recent history of CRC screening
  • Resides in one of the neighborhoods included in the main trial

Exclusion Criteria:

  • Colorectal disease (e.g., ulcerative colitis or colectomy)
  • Personal history of colorectal cancer
  • End-stage or life-threatening diseases
  • Known to be under hospice care
  • Living in a skilled nursing facility
  • Patients who decline research participation will be removed from the patient contact list

Study details
    Colorectal Cancer

NCT06542835

University of Arizona

17 September 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.